Effectiveness and safety of empagliflozin: final results from the EMPRISE study.
Htoo PT, Tesfaye H, Schneeweiss S, Wexler DJ, Everett BM, Glynn RJ, Schmedt N, Koeneman L, Déruaz-Luyet A, Paik JM, Patorno E.
Htoo PT, et al. Among authors: schmedt n.
Diabetologia. 2024 Mar 21. doi: 10.1007/s00125-024-06126-3. Online ahead of print.
Diabetologia. 2024.
PMID: 38509341